# Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

> **NCT06940232** · — · RECRUITING · sponsor: **University of Nebraska** · enrollment: 330 (estimated)

## Conditions studied

- Pediatric Traumatic Brain Injury

## Interventions

- **DIAGNOSTIC_TEST:** Blood Test for Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Acute Biomarkers

## Key facts

- **NCT ID:** NCT06940232
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2027-05
- **Final completion:** 2027-12
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06940232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06940232, "Validating a Blood Test for the Detection of Traumatic Brain Injury in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06940232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
